PRESS-RELEASE ·Filed Mar 19, 2026
Press release: announcement
Actionable Insight • Neutral
No immediate trading implications. Traders should monitor for any unexpected disclosures during or after the AGM, though such events are typically routine for clinical-stage biotechs like Evaxion.
Final — all horizons settled through T+60d
EVAX ▼ -10.00% at T+60d
NEUTRAL call ✗ call lost -10.00% · α vs SPY -24.34% · entry $4.00 → $3.60
T+1d
-2.25%
call -2.25% · α -0.51%
$3.91
settled 7mo ago
T+5d
-10.25%
call -10.25% · α -8.04%
$3.59
settled 6mo ago
T+20d
+11.25%
call +11.25% · α +3.63%
$4.45
settled 6mo ago
T+60d
-10.00%
call -10.00% · α -24.34%
$3.60
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Evaxion announced the convening of its Annual General Meeting on April 16, 2026, to be held at its headquarters in Denmark. The filing contains no material financial updates or operational developments, only administrative details about the meeting.
Key Facts
- Annual General Meeting scheduled for April 16, 2026, at 14:00 CET
- Meeting to be held at Evaxion's offices in Hørsholm, Denmark
- Agenda and proposals available on the company’s investor relations website
- No financial results, guidance, or material corporate updates disclosed
Financial Impact
No financial impact disclosed
Risk Factors
- Lack of near-term catalysts; company remains in clinical development with no commercial revenue
- Forward-looking statements highlight risks around funding, clinical trial success, and market acceptance
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259026 |
36 reports for EVAX
100% Hit rate best @ T+5▲ +22.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $3.07 $3.21 | ▲ +4.56% | ▲ +4.45% | $3.21 (+4.63%) |
Sep 4, 2026 28d ago | 6-K | $3.12 $3.07 | ▲ +1.60% | ▲ +0.39% | $3.21 (−2.96%) |
Aug 20, 2026 6w ago | 6-K | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 20, 2026 6w ago | Press Release | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 17, 2026 6w ago | 6-K | $3.13 $3.40 | ▲ +8.63% | ▲ +9.82% | $3.21 (+2.63%) |
Aug 14, 2026 7w ago | 6-K | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Aug 14, 2026 7w ago | Press Release | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Jul 17, 2026 11w ago | 6-K | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 17, 2026 11w ago | Press Release | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 13, 2026 11w ago | 6-K | $3.02 $3.08 | ▲ +1.82% | ▲ +2.61% | $3.21 (+6.36%) |
Showing 10 of 36
US Market Status
Market Open — Closes in 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access